Form 4: Sight Sciences Executive Purchases Shares in Open Market Transaction
SEC Form 4 Filing
Manohar K. Raheja, EVP of Research & Development at Sight Sciences, acquired 3,376 shares of common stock at $3.89 per share.
Summary
- Manohar K. Raheja, an Executive Vice President at Sight Sciences, purchased 3,376 shares of the company's common stock.
- The transaction occurred on December 3, 2024.
- The purchase price was $3.89 per share.
- Following the transaction, Mr. Raheja directly owns 106,000 shares of Sight Sciences common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive as an executive purchasing shares can indicate confidence, but it's a small transaction and not a major market signal.
Positives
- An executive purchasing shares can be seen as a positive sign of confidence in the company's future prospects.
Industry Context
This is a routine filing related to insider trading activity and is common for publicly traded companies.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
- Similar filings are made by executives at companies like Alcon (ALC) and Johnson & Johnson (JNJ) when they buy or sell shares of their respective companies.
Stakeholder Impact
- The purchase may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/03/2024 | Date of the stock purchase transaction. |
| 12/05/2024 | Date the Form 4 was signed. |
Keywords
Sight Sciences, Manohar K. Raheja, stock purchase, executive, insider trading, SGHT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.